Lincoln Pharmaceuticals reports 28.33 per cent rise in standalone net profit in Q4 FY21
Company recommends dividend of 15 per cent – Rs 1.5 per share for FY21
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IQVIA announces JAPAC expansion of IQVIA Biotech
Since its launch, IQVIA Biotech has initiated hundreds of new trials for biotech companies, including COVID-19 trials
More than 21.89 crore vaccine doses provided to states and UTs: Centre
More than 1.77crore doses still available with States/UTs to be administered
VAV Life Sciences ramps up production of crucial lipid ingredients needed for amphotericin-B
VAV expects with an increased capacity, its lipid raw materials will help pharma companies to add three lakh vials of liposomal…
Bharat Biotech may begin paediatric trials of COVAXIN in June
Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1
Uzbekistan invites Indian companies to explore JVs in seven pharmacological free zones
This opens space for Serum Institute, Bharat Biotech and other Indian vaccine makers to explore joint manufacturing and…
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines:…
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the…
Cadila Healthcare to make around 30 million doses of COVID-19 vaccine a month: Managing Director
The company will use both in-house capacity as well as third-party manufacturers to boost production
Bal Pharma launches BALflu (favipiravir) tablets in India
This formulation is available with 400 mg strength at a price of Rs 85 per tablet
RDIF, Panacea Biotec launch production of Sputnik V in India
RDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V
Vivimed exports its first shipment, Famotidine tablets, to Canada
Famotidine tablets are histamine H2 receptor antagonists used for the treatment of hyperacidity or acid indigestion
Cipla to market Roche’s antibody cocktail pan-India, first batch currently available
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in…
Glenmark gets US FDA nod for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled…
This marks Glenmark’s first synthetic decapeptide injectable approval and will be manufactured in their North American…
Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment
The drug is being offered at Rs 32495 for a 100 mg vial
COVID-19 trials and tribulations for treatments
Dr Arun Bhatt, Consultant – Clinical Research & Drug Development states that in the absence of a peer-reviewed publication in…
COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research
PHE said that while the Pfizer/BioNTech vaccine was 88 per cent effective against symptomatic COVID-19 from the B1.617.2 variant…
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this…
Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish…
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side…
MSN Laboratories launches Posaconazole to treat mucormycosis
MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively